Horizon Discovery Company
Horizon is a gene editing company that designs & engineers genetically-modified cells, applying them to advance human health.
Investors
Founded Date:
2007
Last Funding Type:
Post-IPO Equity
Headquarters:
Cambridge, Cambridgeshire, United Kingdom
Investors Number:
16
Technology:
Others
Employee Number:
251-500
Industry:
PharmTech
Estimated Revenue:
$10M to $50M
Number Of Exists:
Post-IPO Equity
Funding Status:
M&A
Investor Type:
Investor
Total Funding:
$38.5M